Furthermore, in the long-term results with a median follow-up of 110.4 months, patients with CCL2 ≥ 320 pg/mL similarly had significantly shorter OS, PCSS, and CFS than those with CCL2 < 320 pg/mL [18]. Here, CCL2 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.